EconPapers    
Economics at your fingertips  
 

Details about Patricia M. Danzon

Homepage:http://hc.wharton.upenn.edu/danzon/
Workplace:Wharton School, University of Pennsylvania, (more information at EDIRC)

Access statistics for papers by Patricia M. Danzon.

Last updated 2013-02-15. Update your information in the RePEc Author Service.

Short-id: pda291


Jump to Journal Articles Edited books Chapters

Working Papers

2012

  1. Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (1)

2011

  1. Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (3)
  2. Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (2)
  3. Vaccine Supply: Effects Of Regulation And Competition
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
    See also Journal Article in International Journal of the Economics of Business (2011)

2008

  1. Effects of Regulation on Drug Launch and Pricing in Interdependent Markets
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (9)

2004

  1. Mergers and Acquisitions in the Pharmaceutical and Biotech Industries
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (8)
    See also Journal Article in Managerial and Decision Economics (2007)

2003

  1. Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (20)
    See also Journal Article in Journal of Health Economics (2005)
  2. Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (15)
    See also Chapter (2004)
    Journal Article in Forum for Health Economics & Policy (2004)
  3. The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (6)
    See also Journal Article in Health Economics (2005)

2002

  1. Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (18)
  2. Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy
    Center for Policy Research Policy Briefs, Center for Policy Research, Maxwell School, Syracuse University Downloads

1990

  1. Mandated Employment-Based Health Insurance:Incidence and Efficiency Effects
    University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations (2)
  2. The Effects of Malpractice Litigation on Physicians' Fees and Incomes
    University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations (1)
    See also Journal Article in American Economic Review (1990)

Journal Articles

2011

  1. Vaccine Supply: Effects of Regulation and Competition
    International Journal of the Economics of Business, 2011, 18, (2), 239-271 Downloads
    See also Working Paper (2011)

2008

  1. "Crises" in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market
    Journal of Banking & Finance, 2008, 32, (1), 157-169 Downloads View citations (4)

2007

  1. Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion
    Managerial and Decision Economics, 2007, 28, (4-5), 231-250 Downloads View citations (2)
  2. Mergers and acquisitions in the pharmaceutical and biotech industries
    Managerial and Decision Economics, 2007, 28, (4-5), 307-328 Downloads View citations (12)
    See also Working Paper (2004)

2005

  1. Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances
    Journal of Health Economics, 2005, 24, (2), 317-339 Downloads View citations (15)
    See also Working Paper (2003)
  2. The impact of price regulation on the launch delay of new drugs-evidence from twenty-five major markets in the 1990s
    Health Economics, 2005, 14, (3), 269-292 Downloads View citations (17)
    See also Working Paper (2003)

2004

  1. Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand
    Forum for Health Economics & Policy, 2004, 7, (1), 1-56 Downloads View citations (9)
    See also Chapter (2004)
    Working Paper (2003)

2002

  1. A general model of the impact of absenteeism on employers and employees
    Health Economics, 2002, 11, (3), 221-231 Downloads View citations (13)
  2. Welfare effects of supplementary insurance: a comment
    Journal of Health Economics, 2002, 21, (5), 923-926 Downloads View citations (7)

2001

  1. Comments on "The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions."
    The Journal of Legal Studies, 2001, 30, (2), 661-68
  2. Worker's Compensation Rate Regulation: How Price Controls Increase Costs
    Journal of Law and Economics, 2001, 44, (1), 1-36 View citations (3)

2000

  1. Cross-national price differences for pharmaceuticals: how large, and why?
    Journal of Health Economics, 2000, 19, (2), 159-195 Downloads View citations (56)
  2. Does Regulation Drive out Competition in Pharmaceutical Markets?
    Journal of Law and Economics, 2000, 43, (2), 311-57 View citations (49)
  3. Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance
    The Journal of Business, 2000, 73, (4), 569-95 Downloads View citations (1)

1999

  1. Medical negligence and the NHS: an economic analysis
    Health Economics, 1999, 8, (2), 93-101 View citations (3)

1998

  1. The Economics of Parallel Trade
    PharmacoEconomics, 1998, 13, (3), 293-304 Downloads View citations (16)
  2. `The Pros and Cons of a Single Euro-Price for Drugs' and `The Economics of Parallel Trade'
    PharmacoEconomics, 1998, 14, (1), 135-137 Downloads

1997

  1. Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU
    International Journal of the Economics of Business, 1997, 4, (3), 301-322 Downloads View citations (18)
  2. Price, Financial Quality, and Capital Flows in Insurance Markets
    Journal of Financial Intermediation, 1997, 6, (1), 3-38 Downloads View citations (39)
  3. Tort Liability: A Minefield for Managed Care?
    The Journal of Legal Studies, 1997, 26, (2), 491-519 View citations (1)

1995

  1. A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth
    Journal of Policy Analysis and Management, 1995, 14, (4), 636-638 Downloads

1994

  1. Health Care Reform
    Australian Economic Review, 1994, 27, (2), 81-88 Downloads View citations (1)
  2. Price Cutting in Liability Insurance Markets
    The Journal of Business, 1994, 67, (4), 511-38 Downloads View citations (11)
  3. The Swedish patient compensation system: Myths and realities
    International Review of Law and Economics, 1994, 14, (4), 453-466 Downloads View citations (1)
  4. Tort Reform: The Case of Medical Malpractice
    Oxford Review of Economic Policy, 1994, 10, (1), 84-98 View citations (1)

1993

  1. Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment
    Journal of Law and Economics, 1993, 36, (1), 587-94
  2. The Economic Implications of Public Disability Insurance in the United States
    Journal of Labor Economics, 1993, 11, (1), S170-200 Downloads View citations (4)

1991

  1. Liability for Medical Malpractice
    Journal of Economic Perspectives, 1991, 5, (3), 51-69 Downloads View citations (15)
    See also Chapter (2000)

1990

  1. Alternative Liability Regimes for Medical Injuries
    The Geneva Papers on Risk and Insurance - Issues and Practice, 1990, 15, (1), 3-21 Downloads View citations (3)
  2. The Effects of Malpractice Litigation on Physicians' Fees and Incomes
    American Economic Review, 1990, 80, (2), 122-27 Downloads View citations (4)
    See also Working Paper (1990)

1988

  1. The Political Economy of Workers' Compensation: Lessons for Product Liability
    American Economic Review, 1988, 78, (2), 305-10 Downloads

1985

  1. Liability and liability insurance for medical malpractice
    Journal of Health Economics, 1985, 4, (4), 309-331 Downloads View citations (8)

1984

  1. Separation of the redistributive and allocative functions of government: A public choice perspective
    Journal of Public Economics, 1984, 24, (3), 373-380 Downloads View citations (2)
  2. The Frequency and Severity of Medical Malpractice Claims
    Journal of Law and Economics, 1984, 27, (1), 115-48 View citations (17)

1983

  1. Contingent Fees for Personal Injury Litigation
    Bell Journal of Economics, 1983, 14, (1), 213-224 Downloads View citations (20)
  2. Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95
    Journal of Policy Analysis and Management, 1983, 3, (1), 154-154 Downloads
  3. Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50
    Journal of Policy Analysis and Management, 1983, 3, (1), 154-155 Downloads View citations (2)

1982

  1. Hospital `profits': The effects of reimbursement policies
    Journal of Health Economics, 1982, 1, (1), 29-52 Downloads View citations (10)
  2. Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00
    Journal of Policy Analysis and Management, 1982, 2, (1), 141-141 Downloads

Edited books

2012

  1. The Oxford Handbook of the Economics of the Biopharmaceutical Industry
    OUP Catalogue, Oxford University Press

Chapters

2013

  1. Regulation of the Pharmaceutical-Biotechnology Industry
    A chapter in Economic Regulation and Its Reform: What Have We Learned?, 2013, pp 407-484 Downloads View citations (1)

2004

  1. Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand
    A chapter in Frontiers in Health Policy Research, Volume 7, 2004, pp 1-54 Downloads View citations (8)
    See also Working Paper (2003)
    Journal Article in Forum for Health Economics & Policy (2004)

2000

  1. Liability for medical malpractice
    Chapter 26 in Handbook of Health Economics, 2000, vol. 1, pp 1339-1404 Downloads View citations (25)
    See also Journal Article in Journal of Economic Perspectives (1991)

1999

  1. The Effects of Price Regulation on Productivity in Pharmaceuticals
    A chapter in International and Interarea Comparisons of Income, Output, and Prices, 1999, pp 371-418 Downloads View citations (2)
 
Page updated 2014-09-17